Morgan Stanley’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.4B | Sell |
22,266,664
-693,892
| -3% | -$55.5M | 0.08% | 212 |
|
|
2025
Q4 | $2.19B | Buy |
22,960,556
+2,246,308
| +11% | +$220M | 0.13% | 130 |
|
|
2025
Q3 | $2.02B | Buy |
20,714,248
+450,584
| +2% | +$46.7M | 0.12% | 146 |
|
|
2025
Q2 | $2.18B | Buy |
20,263,664
+1,226,748
| +6% | +$124M | 0.14% | 129 |
|
|
2025
Q1 | $1.92B | Sell |
19,036,916
-1,443,859
| -7% | -$145M | 0.14% | 137 |
|
|
2024
Q4 | $1.83B | Buy |
20,480,775
+1,405,614
| +7% | +$124M | 0.13% | 137 |
|
|
2024
Q3 | $1.6B | Buy |
19,075,161
+149,267
| +0.8% | +$11.8M | 0.12% | 159 |
|
|
2024
Q2 | $1.46B | Buy |
18,925,894
+961,111
| +5% | +$70.3M | 0.11% | 167 |
|
|
2024
Q1 | $1.23B | Sell |
17,964,783
-19,558,379
| -52% | -$1.26B | 0.1% | 197 |
|
|
2023
Q4 | $2.17B | Buy |
37,523,162
+16,322,823
| +77% | +$871M | 0.1% | 197 |
|
|
2023
Q3 | $1.12B | Buy |
21,200,339
+481,891
| +2% | +$25.3M | 0.11% | 164 |
|
|
2023
Q2 | $1.12B | Buy |
20,718,448
+386,987
| +2% | +$20.2M | 0.11% | 177 |
|
|
2023
Q1 | $1.02B | Buy |
20,331,461
+1,086,407
| +6% | +$51.2M | 0.11% | 185 |
|
|
2022
Q4 | $890M | Buy |
19,245,054
+6,842,597
| +55% | +$296M | 0.1% | 201 |
|
|
2022
Q3 | $480M | Buy |
12,402,457
+1,537,156
| +14% | +$61.7M | 0.07% | 284 |
|
|
2022
Q2 | $405M | Buy |
10,865,301
+6,142,145
| +130% | +$250M | 0.05% | 349 |
|
|
2022
Q1 | $209M | Sell |
4,723,156
-144,627
| -3% | -$6.27M | 0.03% | 511 |
|
|
2021
Q4 | $207M | Buy |
4,867,783
+92,629
| +2% | +$3.89M | 0.03% | 553 |
|
|
2021
Q3 | $207M | Buy |
4,775,154
+167,459
| +4% | +$7.41M | 0.03% | 516 |
|
|
2021
Q2 | $197M | Buy |
4,607,695
+476,827
| +12% | +$20.1M | 0.03% | 550 |
|
|
2021
Q1 | $160M | Sell |
4,130,868
-2,146,162
| -34% | -$81.2M | 0.02% | 563 |
|
|
2020
Q4 | $226M | Buy |
6,277,030
+1,613,187
| +35% | +$58.1M | 0.03% | 433 |
|
|
2020
Q3 | $178M | Buy |
4,663,843
+295,689
| +7% | +$11.4M | 0.03% | 422 |
|
|
2020
Q2 | $153M | Buy |
4,368,154
+206,563
| +5% | +$7.44M | 0.03% | 425 |
|
|
2020
Q1 | $136M | Sell |
4,161,591
-3,306,420
| -44% | -$129M | 0.04% | 414 |
|
|
2019
Q4 | $338M | Buy |
7,468,011
+727,425
| +11% | +$30.4M | 0.08% | 241 |
|
|
2019
Q3 | $274M | Sell |
6,740,586
-97,640
| -1% | -$4.14M | 0.07% | 269 |
|
|
2019
Q2 | $294M | Sell |
6,838,226
-30,582
| -0.4% | -$1.18M | 0.08% | 253 |
|
|
2019
Q1 | $264M | Sell |
6,868,808
-791,002
| -10% | -$30.2M | 0.07% | 276 |
|
|
2018
Q4 | $271M | Buy |
7,659,810
+702,325
| +10% | +$25.5M | 0.08% | 250 |
|
|
2018
Q3 | $268M | Sell |
6,957,485
-559,899
| -7% | -$19.6M | 0.07% | 288 |
|
|
2018
Q2 | $246M | Buy |
7,517,384
+4,013,765
| +115% | +$121M | 0.07% | 291 |
|
|
2018
Q1 | $95.7M | Sell |
3,503,619
-292,742
| -8% | -$7.96M | 0.03% | 610 |
|
|
2017
Q4 | $94.1M | Buy |
3,796,361
+650,427
| +21% | +$17.9M | 0.03% | 618 |
|
|
2017
Q3 | $91.8M | Buy |
3,145,934
+48,809
| +2% | +$1.35M | 0.03% | 602 |
|
|
2017
Q2 | $85.9M | Sell |
3,097,125
-647,255
| -17% | -$17.2M | 0.03% | 626 |
|
|
2017
Q1 | $93.1M | Buy |
3,744,380
+1,458,906
| +64% | +$35.5M | 0.03% | 598 |
|
|
2016
Q4 | $49.4M | Buy |
2,285,474
+86,009
| +4% | +$1.88M | 0.02% | 884 |
|
|
2016
Q3 | $52.4M | Sell |
2,199,465
-333,406
| -13% | -$7.95M | 0.02% | 827 |
|
|
2016
Q2 | $59.2M | Buy |
2,532,871
+923,375
| +57% | +$20M | 0.02% | 708 |
|
|
2016
Q1 | $30.3M | Sell |
1,609,496
-310,258
| -16% | -$5.45M | 0.01% | 1051 |
|
|
2015
Q4 | $35.4M | Buy |
1,919,754
+194,734
| +11% | +$3.49M | 0.01% | 1007 |
|
|
2015
Q3 | $28.3M | Sell |
1,725,020
-819,948
| -32% | -$14M | 0.01% | 1134 |
|
|
2015
Q2 | $45M | Sell |
2,544,968
-382,438
| -13% | -$6.83M | 0.02% | 928 |
|
|
2015
Q1 | $52M | Buy |
2,927,406
+487,926
| +20% | +$7.71M | 0.02% | 838 |
|
|
2014
Q4 | $32.3M | Buy |
2,439,480
+141,104
| +6% | +$1.8M | 0.01% | 1120 |
|
|
2014
Q3 | $27.1M | Sell |
2,298,376
-240,755
| -9% | -$3.03M | 0.01% | 1203 |
|
|
2014
Q2 | $32.4M | Buy |
2,539,131
+1,164,802
| +85% | +$15.1M | 0.01% | 1055 |
|
|
2014
Q1 | $18.6M | Sell |
1,374,329
-1,385,388
| -50% | -$18.2M | 0.01% | 1433 |
|
|
2013
Q4 | $33.2M | Sell |
2,759,717
-425,565
| -13% | -$5.03M | 0.01% | 975 |
|
|
2013
Q3 | $37.4M | Buy |
3,185,282
+986,193
| +45% | +$10.7M | 0.02% | 818 |
|
|
2013
Q2 | $20.4M | Buy |
+2,199,089
| New | +$18.7M | 0.01% | 1168 |
|
Other funds holding BSX
VCM
VPM
Morgan Stanley's BSX Position: Q1 2026 in Review
Morgan Stanley reduced its Boston Scientific (BSX) stake by 3% in Q1 2026, selling an estimated $55.5M and leaving 22,266,664 shares worth $1.4B. The position accounts for 0.08% of the portfolio, ranked #212.
Morgan Stanley first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.19B in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Morgan Stanley held 22,266,664 shares of Boston Scientific worth $1.4B as of Q1 2026.
- Morgan Stanley sold 693,892 Boston Scientific shares in Q1 2026, an estimated $55.5M.
- Boston Scientific made up 0.08% of Morgan Stanley's portfolio in Q1 2026, its #212 holding.
- Morgan Stanley first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Boston Scientific position peaked at $2.19B in Q4 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.